Patents by Inventor Michael Esser

Michael Esser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR ISOLATING AN AQUEOUS HYDROCHLORIC ACID SOLUTION OF FECL3 FROM AN AQUEOUS MULTI-COMPONENT SYSTEM
    Publication number: 20230391634
    Abstract: The invention relates to a method for isolating an aqueous hydrochloric acid solution of FeCl3 from an aqueous multi-component system.
    Type: Application
    Filed: February 21, 2022
    Publication date: December 7, 2023
    Inventors: Michael ESSER, Stephanie PEPER, Karsten BECKER, Werner BÄCKER
  • Air register assembly
    Patent number: 11697325
    Abstract: A vehicle air register assembly includes a housing defining a cavity. An upstream portion of the cavity is disposed proximate to an inlet and a downstream portion of the cavity is disposed proximate to an outlet. Vertical vanes are disposed within the upstream portion. The vertical vanes direct air in a horizontal direction. A horizontal vane assembly is disposed within the downstream portion. The horizontal vane assembly directs the air in a vertical direction. The horizontal vane assembly includes at least one horizontal vane including a driver portion rotatably coupled to the housing proximate to the outlet and a follower portion coupled to the housing proximate to the upstream portion. The follower portion is rotatably coupled to the driver portion.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: July 11, 2023
    Assignee: Ford Global Technologies, LLC
    Inventors: George David Koch Smith, Steven Nicholas Fidh, Brent Clifford Dalton, Anthony Michael Esser, Martin Alfred Lindell
  • AIR REGISTER ASSEMBLY
    Publication number: 20220371409
    Abstract: A vehicle air register assembly includes a housing defining a cavity. An upstream portion of the cavity is disposed proximate to an inlet and a downstream portion of the cavity is disposed proximate to an outlet. Vertical vanes are disposed within the upstream portion. The vertical vanes direct air in a horizontal direction. A horizontal vane assembly is disposed within the downstream portion. The horizontal vane assembly directs the air in a vertical direction. The horizontal vane assembly includes at least one horizontal vane including a driver portion rotatably coupled to the housing proximate to the outlet and a follower portion coupled to the housing proximate to the upstream portion. The follower portion is rotatably coupled to the driver portion.
    Type: Application
    Filed: May 18, 2021
    Publication date: November 24, 2022
    Applicant: Ford Global Technologies, LLC
    Inventors: George David Koch Smith, Steven Nicholas Fidh, Brent Clifford Dalton, Anthony Michael Esser, Martin Alfred Lindell
  • Method for preparing cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives
    Patent number: 10577320
    Abstract: The present invention relates to novel methods for preparing cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives and also to novel intermediates and starting compounds, which are passed through or used in the method according to the invention.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: March 3, 2020
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Taraneh Farida, Martin Littmann, Rafael Warsitz, Michael Esser, Albert Schnatterer
  • Method for producing acylsulfamoylbenzamides
    Patent number: 10513490
    Abstract: The invention relates to a method for producing compounds of formula (Ia), in particular to a method for producing N-[4-(cyclopropylcarbamoyl)phenylsulfonyl]-2-methoxybenzamide.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: December 24, 2019
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Taraneh Farida, Michael Esser, Hubertus Stakemeier
  • Method for preparing cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives
    Publication number: 20190144385
    Abstract: The present invention relates to novel methods for preparing cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives and also to novel intermediates and starting compounds, which are passed through or used in the method according to the invention.
    Type: Application
    Filed: April 26, 2017
    Publication date: May 16, 2019
    Inventors: Taraneh FARIDA, Martin LITTMANN, Rafael WARSITZ, Michael ESSER, Albert SCHNATTERER
  • METHOD FOR PRODUCING ACYLSULFAMOYLBENZAMIDES
    Publication number: 20180118670
    Abstract: The invention relates to a method for producing compounds of formula (Ia), in particular to a method for producing N-[4-(cyclopropylcarbamoyl)phenylsulfonyl]-2-methoxybenzamide.
    Type: Application
    Filed: April 4, 2016
    Publication date: May 3, 2018
    Inventors: Taraneh FARIDA, Michael ESSER, Hubertus STAKEMEIER
  • Process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives
    Patent number: 9840459
    Abstract: The present invention relates to a novel process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives, and also to novel intermediates and starting materials which are produced and/or used in the process according to the invention.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: December 12, 2017
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Taraneh Farida, Berndt Maiwald, Martin Littmann, Winfried Etzel, Rafael Warsitz, Nicolas Henck, Michael Esser
  • PROCESS FOR PREPARING CIS-ALKOXY-SUBSTITUTED SPIROCYCLIC PHENYLACETYLAMINO ACID ESTERS AND CIS- ALKOXY-SUBSTITUTED SPIROCYCLIC 1H- PYRROLIDINE-2,4-DIONE DERIVATIVES
    Publication number: 20160264516
    Abstract: The present invention relates to a novel process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives, and also to novel intermediates and starting materials which are produced and/or used in the process according to the invention.
    Type: Application
    Filed: May 23, 2016
    Publication date: September 15, 2016
    Inventors: Taraneh FARIDA, Berndt MAIWALD, Martin LITTMANN, Winfried ETZEL, Rafael WARSITZ, Nicolas HENCK, Michael ESSER
  • Process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis- alkoxy-substituted spirocyclic 1H- pyrrolidine-2,4-dione derivatives
    Patent number: 9376374
    Abstract: The present invention relates to a novel process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives, and also to novel intermediates and starting materials which are produced and/or used in the process according to the invention.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: June 28, 2016
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Taraneh Farida, Berndt Maiwald, Martin Littmann, Winfried Etzel, Rafael Warsitz, Nicolas Henck, Michael Esser
  • Heterobicyclic metalloprotease inhibitors
    Patent number: 8835441
    Abstract: The present invention relates generally to amide containing heterobicyclic compounds having the following formulas: wherein R1, R2, D, and Q are as defined in the specification. More particularly, the present invention provides a new class of amide containing heterobicyclic compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: September 16, 2014
    Assignee: Amgen Inc.
    Inventors: Christoph Steeneck, Christian Gege, Frank Richter, Heiko Kroth, Matthias Hochgürtel, Michael Essers, Joshua van Veldhuizen, Bert Nolte, Brian M. Gallagher, Jr., Tim Feuerstein, Matthias Schneider, Torsten Arndt, Hongbo Deng, Ralf Biesinger, Xinyuan Wu, Harald Bluhm, Irving Sucholeiki, Arthur G. Taveras
  • HETEROBICYCLIC METALLOPROTEASE INHIBITORS
    Publication number: 20120015920
    Abstract: The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
    Type: Application
    Filed: June 17, 2011
    Publication date: January 19, 2012
    Applicant: Alantos Pharmaceuticals Holding, Inc.
    Inventors: Christoph Steeneck, Christian Gege, Frank Richter, Heiko Kroth, Matthias Hochgürtel, Michael Essers, Joshua van Veldhuizen, Bert Nolte, Brian M. Gallagher, JR., Tim Feuerstein, Matthias Schneider, Torsten Arndt, Hongbo Deng, Ralf Biesinger, Xinyuan Wu, Harald Bluhm, Irving Sucholeiki, Arthur G. Taveras
  • Dipeptidyl peptidase-IV inhibitors
    Patent number: 8076330
    Abstract: The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes.
    Type: Grant
    Filed: January 13, 2011
    Date of Patent: December 13, 2011
    Assignee: Amgen Inc.
    Inventors: Heiko Kroth, Tim Feuerstein, Frank Richter, Jürgen Boer, Michael Essers, Bert Nolte, Matthias Schneider, Matthias Hochgürtel, Fritz-Frieder Frickel, Arthur G. Taveras, Christoph Steeneck
  • Dipeptidyl Peptidase-IV Inhibitors
    Publication number: 20110112051
    Abstract: The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes.
    Type: Application
    Filed: January 13, 2011
    Publication date: May 12, 2011
    Applicant: Alantos Pharmaceuticals Holding, Inc.
    Inventors: Heiko KROTH, Tim Feuerstein, Frank Richter, Jürgen Boer, Michael Essers, Bert Nolte, Matthias Schneider, Matthias Hochguertel, Fritz-Frieder Frickel, Arthur Taveras, Christoph Steeneck
  • DIPEPTIDYL PEPTIDASE-IV INHIBITORS
    Publication number: 20100009961
    Abstract: The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes.
    Type: Application
    Filed: June 26, 2009
    Publication date: January 14, 2010
    Applicant: Alantos Pharmaceuticals Holding, Inc.
    Inventors: Heiko Kroth, Tim Feuerstein, Frank Richter, Jurgen Boer, Michael Essers, Bert Nolte, Matthias Schneider, Matthias Hochguertel, Fritz-Frieder Frickel, Arthur Taveras, Christoph Steeneck
  • Heterobicyclic Metalloprotease Inhibitors
    Publication number: 20090312312
    Abstract: The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
    Type: Application
    Filed: February 12, 2009
    Publication date: December 17, 2009
    Applicant: ALANTOS PHARMACEUTICALS HOLDING, INC.
    Inventors: Christoph STEENECK, Christian GEGE, Frank RICHTER, Heiko KROTH, Matthias HOCHGURTEL, Michael ESSERS, Joshua VAN VELDHUIZEN, Bert NOLTE, Brian M. GALLAGHER, JR., Tim FEUERSTEIN, Matthias SCHNEIDER, Torsten ARNDT, Hongbo DENG, Ralf BIESINGER, Xinyuan WU, Harald BLUHM, Irving SUCHOLEIKI, Arthur G. TAVERAS
  • Heterobicyclic metalloprotease inhibitors
    Publication number: 20080221092
    Abstract: The present invention relates generally to amide containing heterobicyclic containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-3 and/or MMP-13 inhibiting compounds that exhibit an increased potency and selectivity in relation to currently known MMP-13 and MMP-3 inhibitors.
    Type: Application
    Filed: November 20, 2007
    Publication date: September 11, 2008
    Inventors: Harald Bluhm, Matthias Hochgurtel, Heiko Kroth, Michael Essers, Christian Gege, Frank Richter, Arthur Taveras
  • Heterobicyclic metalloprotease inhibitors
    Publication number: 20080221083
    Abstract: The present invention relates generally to amide containing heterobicyclic containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-3 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13 and MMP-3 inhibitors.
    Type: Application
    Filed: November 20, 2007
    Publication date: September 11, 2008
    Inventors: Matthias Hochgurtel, Harald Bluhm, Heiko Kroth, Michael Essers, Christian Gege, Arthur Taveras
  • Heterobicyclic metalloprotease inhibitors
    Publication number: 20080161300
    Abstract: The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
    Type: Application
    Filed: December 7, 2007
    Publication date: July 3, 2008
    Applicant: Alantos Pharmaceuticals Holding, Inc.
    Inventors: Christoph Steeneck, Christian Gege, Frank Richter, Heiko Kroth, Matthias Hochgurtel, Michael Essers, Joshua Van Veldhuizen, Bert Nolte, Brian Gallagher, Tim Feuerstein, Matthias Schneider, Torsten Arndt, Hongbo Deng, Ralf Beisinger, Xinyuan Wu, Harald Bluhm, Irving Sucholeiki, Arthur Taveras
  • Liquid crystal display, backlight of such display, and a method of lighting a liquid crystal display
    Patent number: 7287893
    Abstract: A liquid crystal display includes a backlight device which having a housing in which at least one tube-like fluorescent lamp is present. The housing forms a substantially dust-proof space. Part of the lamp extends outside the housing through a wall of the housing, which wall abuts against the lamp in a substantially dust-tight manner at the location where the lamp passes through the wall.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: October 30, 2007
    Assignee: Koninklijke Philips Electronics, N.V.
    Inventors: Wanda Susanne Kruijt, Boudewijn Michael Esser, Jan Marinus Van Oostveen, Adrianus Christianus Wilhelmus Custers